Technical Analysis for ATRA - Atara Biotherapeutics, Inc.

Grade Last Price % Change Price Change
F 12.77 -2.07% -0.27
ATRA closed down 2.07 percent on Friday, July 23, 2021, on 62 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: Aug 3
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ATRA trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -2.07%
Wide Bands Range Expansion -2.07%
Oversold Stochastic Weakness -2.07%
Slingshot Bearish Bearish Swing Setup -4.84%
Wide Bands Range Expansion -4.84%
Oversold Stochastic Weakness -4.84%
Bullish Engulfing Bullish -2.96%
Stochastic Buy Signal Bullish -2.96%
Older End-of-Day Signals for ATRA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % 3 days ago
Possible NR7 3 days ago
Down 1% 3 days ago
Up 1% 3 days ago
Fell Below Previous Day's Low 3 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of muscle wasting conditions and oncology. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. The company is also developing STM 434, a targeted therapy for ovarian cancer and other solid tumors; and a pipeline of product candidates that are in preclinical development. Atara Biotherapeutics, Inc. was founded in 2012 and is headquartered in Brisbane, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Clinical Development Solid Tumors Drugs Ovarian Cancer Targeted Therapy Renal Disease End Stage Renal Disease Stage Renal Disease

Is ATRA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.2
52 Week Low 11.33
Average Volume 690,185
200-Day Moving Average 16.64
50-Day Moving Average 14.36
20-Day Moving Average 14.34
10-Day Moving Average 13.36
Average True Range 0.58
ADX 24.94
+DI 15.36
-DI 28.59
Chandelier Exit (Long, 3 ATRs) 15.10
Chandelier Exit (Short, 3 ATRs) 14.47
Upper Bollinger Bands 16.64
Lower Bollinger Band 12.04
Percent B (%b) 0.16
BandWidth 32.06
MACD Line -0.50
MACD Signal Line -0.31
MACD Histogram -0.1879
Fundamentals Value
Market Cap 992.41 Million
Num Shares 77.7 Million
EPS -6.07
Price-to-Earnings (P/E) Ratio -2.10
Price-to-Sales 0.00
Price-to-Book 5.14
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.46
Resistance 3 (R3) 13.52 13.35 13.35
Resistance 2 (R2) 13.35 13.17 13.32 13.31
Resistance 1 (R1) 13.06 13.07 12.98 13.00 13.27
Pivot Point 12.89 12.89 12.85 12.86 12.89
Support 1 (S1) 12.60 12.71 12.52 12.54 12.27
Support 2 (S2) 12.43 12.61 12.40 12.23
Support 3 (S3) 12.14 12.43 12.20
Support 4 (S4) 12.08